Board No.           

             

OSTEOARTHRITIS


P01      RESVERATROL REGULATES THE WNT/ß-CATENIN PATHWAY IN HUMAN
            OSTEOARTHRITIS OSTEOBLASTS

Elie Abed, Canada


P02      ULTRASOUND DETECTED INFLAMMATION IS ASSOCIATED WITH THE DEVELOPMENT
            OF NEW BONE EROSIONS IN HAND OSTEOARTHRITIS: A LONGITUDINAL SINGLE JOINT STUDY

Olga Addimanda, Italy


P03      RELATIONSHIP OF A XANTHINE OXIDASE (XO) SINGLE NUCLEOTIDE POLYMORPHISM TO DOSE
            OF XO INHIBITOR

Kristen Cook, USA


P04      MEASUREMENT OF ISOKINETIC QUADRICEPS MUSCLE STRENGTH AND PAIN IN
            OBESE AND NON-OBESE INDIVIDUALS WITH KNEE OSTEOARTHRITIS

Kamary Coriolano, Canada


P05      RILONACEPT IN THE TREATMENT OF SUBACROMIAL BURSITIS: A RANDOMIZED,
            NON-INFERIORITY, UNBLINDED STUDY VERSUS TRIAMCINOLONE ACETONIDE

Cassandra Leigh Craig, USA


P06      SUCCESSFUL TEMPOROMANDIBULAR VISCOSUPPLEMENTATION PROTOCOL IN A 47-
            YEAR-OLD WOMAN WITH A 10-YEAR HISTORY OF TEMPOROMANDIBULAR PAIN AND IMPAIRED
            FUNCTION

Camila Megale de Almeida-Leite, Brazil


P07      ARTHROCENTENTESIS ASSOCIATED WITH VISCOSUPPLEMENTATION IN A CASE OF
            ANTERIOR DISC DISPLACEMENT AND ATTACHMENT IN TEMPOROMANDIBULAR JOINT

Camila Megale de Almeida-Leite, Brazil


P08      PHYSICAL ACTIVITY AND KNEE OSTEOARTHRITIS: WHAT DOES THE LITERATURE SAY SO
            FAR?

Nathaly Gaudreault, Canada


P09      OSTEOARTHRITIS-ASSOCIATED PAIN IN CATS: PROOFS OF CENTRAL SENSITIZATION
            DEVELOPMENT

Martin Guillot, Canada


P10      WHAT DO WE KNOW ABOUT THE CURRENT MANAGEMENT OF LOW BACK PAIN IN
            PRIMARY CARE? A GLOBAL SCOPING REVIEW

Amanda Hall, UK


P11      MEASUREMENT OF THE INJECTION DEPTH OF QUADRATUS LUBORUM(QL) UNDER
            ULTRASONOGRAPHY IN LOW BACK PAIN (LBP) KOREAN PATIENTS

Won Hyung Lee, Korea


P12      ELEVATED ENDOGENOUS DICKKPOF-2 LEVELS IN HUMAN OSTEOARTHRITIC
            OSTEOBLASTS ARE RESPONSIBLE FOR THEIR ALTERED RESPONSE TO PARATHYROID
            HORMONE AND ALTERED RECYCLING OF PTH RECEPTORS

Daniel Lajeunesse, Canada


P13      ONE-YEAR KINETIC AND STRUCTURAL EVALUATION FOLLOWING LATERAL SUTURE
            STABILISATION IN A CANINE EXPERIMENTALLY INDUCED CRANIAL CRUCIATE - DEFICIENT
            STIFLE MODEL

Bertrand Lussier, Canada


P14      POST-TRAUMATIC OSTEONECROSIS OF DISTAL TIBIA AFTER OPEN ANKLE FRACTURE

Martin Majewski, Switzerland


P15      THE LEVELS OF THE ADIPOKINES LEPTIN, ADIPSIN AND ADIPONECTIN PREDICT KNEE
            OSTEOARTHRITIS PROGRESSION AS ASSESSED BY MRI AND TOTAL KNEE REPLACEMENT
            OCCURRENCE IN SYMPTOMATIC PATIENTS

Johanne Martel-Pelletier, Canada


P16      IS fMRI AN ADEQUATED TOOL TO DISCRIMINATE CENTRAL SENSITISATION PHENOMENA IN
            PATIENTS WITH KNEE OSTEOARTHRITIS?

Jordi Monfort, Spain


P17      ANALGESIC EFFICACY OF MELOXICAM AS A GINGIVAL SPRAY FORMULATION, ALONE
            OR IN COMBINATION WITH TRAMADOL, IN CATS WITH NATURALLY OCCURRING
            OSTEOARTHRITIS

Beatriz Paglerani Monteiro, Canada


P18      ANALGESIC EFFICACY OF TRAMADOL ADMINISTERED ORALLY FOR TWO WEEKS IN
            CATS WITH NATURALLY OCCURRING OSTEOARTHRITIS

Beatriz  Paglerani Monteiro, Canada


P19      DOES A PLACEBO-EFFECT EXIST IN PRIVATELY-OWNED DOGS WITH
            OSTEOARTHRITIS? A RESPONDER ANALYSIS

Maxim Moreau, Canada


P20      ROAD SCALED AFFINITY PROTEOMIC PROFILING OF AUTOANTIBODY REPERTOIRES
            AND PROTEIN LEVELS IN SERUM ENABLES DISCOVERY OF POTENTIAL NOVEL MARKERS
            WITHIN OSTEOARTHRITIS

Peter Nilsson, Sweden


P21      CONCURRENT VALIDITY OF DIFFERENT PAIN ASSESSMENT METHODS IN THE RAT
            OSTEOARTHRITIS MIA MODEL

Colombe Otis, Canada


P22      MANAGEMENT OF EXTENSIVE OSTEOCHONDRAL NECROSIS ASSISTED WITH PLASMA
            RICH IN GROWTH FACTORS AND OSTEOCHONDRAL ALLOGRAFT

Sabino Padilla, Spain


P23      A MULTIPLEX BEAD-BASED IMMUNOASSAY (LUMINEX) FOR THE ANALYSIS OF
            INFLAMMATORY CYTOKINES IN MONKEY PLASMA

Photini Pitsikas, Canada


P24      VASTUS MEDIALIS MUSCLE FAT CONTENT AS ASSESSED BY MRI IS A RISK FACTOR
            FOR KNEE OSTEOARTHRITIS PROGRESSION: RELEVANCE FROM A CLINICAL TRIAL

Jean-Pierre Raynauld, Canada


P25      GALECTIN-3 INDUCES REGULATION OF COLLAGENASE 1 THROUGH MAINLY SLC3A2
            IN HUMAN OSTEOARTHRITIS OSTEOBLASTS

Pascal Reboul, France


P26      INTRA-ARTICULAR INJECTION OF HYALURONIC ACID COMBINED WITH SORBITOL IN
            THE TREATMENT OF OSTEOARTHRITIS IN HORSES

Didier Serteyn, Belgium


P27      ADIPOKINE PROFILE OF SYNOVIAL FLUID IN END-STAGE KNEE OSTEOARTHRITIS: AN
            INVESTIGATION ACROSS RACIAL GROUPS

Anirudh Sharma, Canada


P28      CAUSES OF THE INITIATION AND PROGRESSION OF POST-TRAUMATIC OSTEOARTHRITIS

Nigel Shrive, Canada


P29      IN VIVO CARTILAGE-SPECIFIC DELETION OF EPHRIN-B2 IN MICE RESULTS IN BONE
            DEVELOPMENT LEADING TO OSTEOARTHRITIS FEATURES

Gladys Valverde-Franco, Canada


P30      PSYCHOLOGICAL CONTRIBUTIONS TO QUALITY OF LIFE IN INDIVIDUALS WITH
            ADVANCED OSTEOARTHRITIS OF THE KNEE

Esther Yakobov, Canada


P31      WHEN IS IT SAFE FOR PATIENTS TO DRIVE AFTER RIGHT TOTAL KNEE ARTHROPLASTY?

Victoria Younger, USA


P32      PREDICTORS OF PREDICTORS OF EARLY DISCHARGE AFTER TOTAL KNEE REPLACEMENT

Victoria Younger, USA


OSTEOPOROSIS


P33      THE EFFECT OF PARITY AND LACTATION ON BONE MINERAL DENSITY AMONG SAUDI
            WOMEN, JEDDAH

Rajaa Mohammad Al-Raddadi, Saudi Arabia


P34      UP TO HALF OF FIRST FRAGILITY FRACTURES (FF), AND A THIRD OF RECURRENT FF,
            OCCUR IN PATIENTS WITH LOW OR MODERATE ESTIMATED FRAX® 10-YEAR
            FRACTURE RISK: RESULTS FROM THE OPTIMUS INITIATIVE

Pierre-Marc April, Canada


P35      HEALTHY AGING: POSTURAL EDUCATION ON ELDERLY PEOPLE IN THE
            MANAGEMENT OF OSTEOPOROSIS

Ilaria Bortone, Italy


P36      SAFETY ASSESSMENT OF MULTIPLE FLUOROCHROME LABELS ADMINISTERED BY
            SUBCUTANEOUS INJECTION IN MONKEYS

Melanie Felx, Canada


P37      CHANGE OF MUSCLE PERCENTAGE WITH AGE AND SCAMMON’S GROWTH CURVES
            RELATIONAL COMPOSITION OF CHANGE IN BMI AND FAT PERCENTAGE WITH AGE

Katsunori Fujii, Japan


P38      POSITIVE EFFECT OF ALENDRONATE AND ULTRAVIOLET-PHOTOFUNCTIONALIZATION
            ON IMPLANT SURFACE

Jae In Lee, Canada


P39      PREVALENCE OF OSTEOPOROSIS IN PATIENTS WITH PERIPROSTHETIC AND PERI-
            IMPLANT FEMUR FRACTURES

Suzanne Morin, Canada


P40      YM-175 INDUCES APOPTOSIS OF HUMAN NATIVE MONOCYTE-LINEAGE CELLS BY
            THE INHIBITION OF PRENYLATION

Naoki Takezako, Japan

 

P41      SEVERE HYPOCALCEMIA FOLLOWING ADMINISTRATION OF ZOLEDRONIC ACID IN AN OSTEOPOROTIC PATIENT WITH A HISTORY OF ROUX-EN-Y GASTRIC BYPASS
Joshua Tate, USA


P42      FACTORS ASSOCIATED WITH NON-PERSISTENCE AND NON-ADHERENCE TO
            DENOSUMAB AND ZOLEDRONIC ACID: A POPULATION-BASED COHORT STUDY

Eric Tremblay, Canada


RHEUMATOID ARTHRITIS


P43      AUTOANTIBODIES TO XANTHINE OXIDASE AND STREPTOLYSINE AND LEVELS OF THE
            COMPLEMENT IN SYNOVIAL FLUIDS FROM RHEUMATOID ARTHRITIS AND OTHER  
            JOINT DISEASES

Lekhmici Arrar, Algeria


P44      HEART VALVE DISEASE IN A NEW MODEL OF RHEUMATOID ARTHRITIS

            Philippe Bouillet, Australia


P45       PLATELET-DERIVED GROWTH FACTOR RECEPTOR ACTIVATION PROMOTES THE PRO-
             DESTRUCTIVE INVADOSOME-FORMING PHENOTYPE OF RHEUMATOID ARTHRITIS
             SYNOVIOCYTES

 Martine Charbonneau, Canada

P46       SNAIL IS A CRITICAL MEDIATOR OF INVADOSOME FORMATION AND JOINT
             DEGRADATION IN ARTHRITIS

 Martine Charbonneau, Canada


P47       USE OF RITUXIMAB COMPARED TO ANTI-TNF AGENTS AS SECOND AND THIRD LINE
             THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS. A REPORT FROM THE
             RHUMADATA® CLINICAL DATABASE AND REGISTRY

 Denis Choquette, Canada


P48       PRESENCE OF VITAMIN B12 DEFICIENCY AND ANTI-GASTRIC PARIETAL CELL
             ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS

 Cassandra Leigh Craig, USA


P49       ANALYSIS OF ULTRASOUND KNEE FINDINGS IN DIFFERENT RHEUMATIC DISEASES IN
             EGYPTIAN PATIENTS

 Nevin Hammam, Egypt


P50       CORRELATION BETWEEN OCULAR SURFACE ABNORMALITIES AND DISEASE
             ACTIVITY IN RHEUMATOID ARTHRITIS

 Nevin Hammam, Egypt


P51       DENOSUMAB, BIOLOGICS AND THE RISK OF INFECTION IN PATIENTS WITH
             RHEUMATOID ARTHRITIS

 Boulos Haraoui, Canada


P52       PREDICTORS OF ACR/EULAR BOOLEAN AND SDAI REMISSION IN PATIENTS WITH
             ESTABLISHED RHEUMATOID ARTHRITIS TREATED WITH ANTI-TNF: AN ANALYSIS
             FROM THE PROSPECTIVE, OBSERVATIONAL REGISTRY, BIOTRAC

 Boulos Haraoui, Canada


P53       THE DIAGNOSTIC DELAY IN SPONDYLOARTHRITIS IS IMPROVING

 Manfred Herold, Austria


P54       WHAT IS MORE PREDICTIVE OF ACHIEVING REMISSION AT 12 MONTHS: THE
             PERCENTAGE OF BASELINE IMPROVEMENT OR THE ACTUAL DISEASE STATE  
             ACHIEVED?

 François Nantel, Canada


P55       FATIGUE, SLEEP QUALITY, MOOD DISTURBANCES AND DISEASE ACTIVITY IN
             RHEUMATOID ARTHRITIS PATIENTS: ARE THEY CORRELATED?

 Nevin Hammam, Egypt


P56       SOLUBLE INTERLEUKIN-15 RECEPTOR ALPHA IS INCREASED IN RHEUMATOID
             ARTHRITIS AND ITS PRO-INFLAMMATORY ROLE COULD BE INHIBITED BY IL-15
             ANTAGONIST PEPTIDE CIGB55

 Alicia Santos Savio, Cuba


P57       PREDICTION OF REMISSION BY PATIENTS AND PHYSICIANS: DOES THE DOCTOR
             KNOW BEST?

 Cathy Tkaczyk, Canada


P58       THE ROLE OF EFNB1 AND EFNB2 IN MOUSE COLLAGEN-INDUCED ARTHRITIS AND
             HUMAN RHEUMATOID ARTHRITIS

 Yan Hu, Canada


P59       AUTOIMMUNE HEPATITIS: AN UNKNOWN EXTRA ARTICULAR MANIFESTATION OF
             RHEUMATOID ARTHRITIS

 Meera Yogarajah, USA

P60       ADOLESCENT OSTEOMALACIA IN SAUDI ARABIA:  A HOSPITAL-BASED STUDY

             Nasir Al Jurayyan, Saudi Arabia